Literature DB >> 31975425

Protein kinase A facilitates relaxation of mouse ileum via phosphorylation of neuronal nitric oxide synthase.

Damian D Guerra1, Rachael Bok1, Ramón A Lorca1, K Joseph Hurt1,2.   

Abstract

BACKGROUND AND
PURPOSE: The enteric neurotransmitter nitric oxide (NO) regulates gastrointestinal motility by relaxing smooth muscle. Pharmacological cAMP induction also relaxes gastrointestinal smooth muscle, but it is uncertain whether cAMP augments or suppresses enteric NO signalling. In other organ systems, cAMP can increase neuronal NO production by stimulating protein kinase A (PKA) to phosphorylate neuronal NOS (nNOS) Serine-1412 (S1412). We hypothesized that cAMP also increases nNOS S1412 phosphorylation by PKA in enteric neurons to augment nitrergic relaxation of mouse ileum. EXPERIMENTAL APPROACH: We measured contractile force and nNOS S1412 phosphorylation in ileal rings suspended in an organ bath. We used forskolin to induce cAMP-dependent relaxation of wild type, nNOSS1412A knock-in and nNOSα-null ileal rings in the presence or absence of PKA, protein kinase B (Akt) and NOS inhibitors. KEY
RESULTS: Forskolin stimulated phosphorylation of nNOS S1412 in mouse ileum. Forskolin relaxed nNOSα-null and nNOSS1412A ileal rings less than wild-type ileal rings. PKA inhibition blocked forskolin-induced nNOS phosphorylation and attenuated relaxation of wild type but not nNOSS1412A ileum. Akt inhibition did not alter nNOS phosphorylation with forskolin but did attenuate relaxation of wild type and nNOSS1412A . NOS inhibition with L-NAME eliminated the effects of PKA and Akt inhibitors on relaxation. CONCLUSION AND IMPLICATIONS: PKA phosphorylation of nNOS S1412 augments forskolin-induced nitrergic ileal relaxation. The relationship between cAMP/PKA and NO is therefore synergistic in enteric nitrergic neurons. Because NO regulates gut motility, selective modulation of enteric neuronal cAMP synthesis may be useful for the treatment of gastrointestinal motility disorders.
© 2020 The British Pharmacological Society.

Entities:  

Year:  2020        PMID: 31975425      PMCID: PMC7236076          DOI: 10.1111/bph.15001

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  72 in total

1.  Inhibition of protein kinase A in murine enteric neurons causes lethal intestinal pseudo-obstruction.

Authors:  Douglas G Howe; Christine M Clarke; Huijun Yan; Brandon S Willis; David A Schneider; G Stanley McKnight; Raj P Kapur
Journal:  J Neurobiol       Date:  2006-02-15

2.  A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis.

Authors:  Luca Antonioli; Matteo Fornai; Rocchina Colucci; Narcisa Ghisu; Corrado Blandizzi; Mario Del Tacca
Journal:  Inflamm Bowel Dis       Date:  2006-02       Impact factor: 5.325

3.  The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.

Authors:  R Boer; W R Ulrich; T Klein; B Mirau; S Haas; I Baur
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

4.  Cyclic AMP-dependent phosphorylation of neuronal nitric oxide synthase mediates penile erection.

Authors:  K Joseph Hurt; Sena F Sezen; Gwen F Lagoda; Biljana Musicki; Gerald A Rameau; Solomon H Snyder; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

5.  Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation.

Authors:  J Hannibal; E Ekblad; H Mulder; F Sundler; J Fahrenkrug
Journal:  Cell Tissue Res       Date:  1998-01       Impact factor: 5.249

6.  Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus.

Authors:  R A Lefebvre; G J Smits; J P Timmermans
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

7.  Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation.

Authors:  A S Khromov; H Wang; N Choudhury; M McDuffie; B P Herring; R Nakamoto; G K Owens; A P Somlyo; A V Somlyo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

8.  Effects of forskolin on electrical behaviour of myenteric neurones in guinea-pig small intestine.

Authors:  P R Nemeth; J M Palmer; J D Wood; D H Zafirov
Journal:  J Physiol       Date:  1986-07       Impact factor: 5.182

Review 9.  Endothelial nitric oxide synthase in red blood cells: key to a new erythrocrine function?

Authors:  Miriam M Cortese-Krott; Malte Kelm
Journal:  Redox Biol       Date:  2014-01-09       Impact factor: 11.799

10.  THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets.

Authors:  Stephen P H Alexander; Eamonn Kelly; Alistair Mathie; John A Peters; Emma L Veale; Jane F Armstrong; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; O Peter Buneman; John A Cidlowski; Arthur Christopoulos; Anthony P Davenport; Doriano Fabbro; Michael Spedding; Jörg Striessnig; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2019-12       Impact factor: 8.739

View more
  3 in total

1.  In vitro effects of essential oils of Tanacetum balsamita and carvone on the contractility of bovine ileum smooth muscles.

Authors:  Masoud Ahmadnejad-Asl-Gavgani; Masoud Maham; Bahram Dalair-Naghadeh
Journal:  Vet Res Forum       Date:  2022-03-15       Impact factor: 0.950

2.  Protein kinase A facilitates relaxation of mouse ileum via phosphorylation of neuronal nitric oxide synthase.

Authors:  Damian D Guerra; Rachael Bok; Ramón A Lorca; K Joseph Hurt
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

Review 3.  Role of neuronal nitric oxide synthase on cardiovascular functions in physiological and pathophysiological states.

Authors:  Ahmmed Ally; Isabella Powell; Minori M Ally; Kevin Chaitoff; Surya M Nauli
Journal:  Nitric Oxide       Date:  2020-06-23       Impact factor: 4.427

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.